Schramm 2005.
| Methods | A cost‐effectiveness study for the Swiss public health insurance system |
| Participants | Patients with moderate to severe COPD |
| Interventions | Tiotropium compared to ipratropium, salmeterol or standard care |
| Outcomes | Exacerbations, hospitalisations, direct yearly total cost for COPD therapy |
| Notes | Pending access to full article and translation |
COPD: chronic obstructive pulmonary disease; FEV1: forced expiratory volume in one second; QALY: quality‐adjusted life year; SGRQ: St George's Respiratory Questionnaire; TDI: Transitional Dyspnoea Index